Abstract:BACKGROUND:Retinal degeneration is a leading cause of blindness in the world; its etiology is complex and involves genetic defects and stress-associated aging. In addition to gene therapies for known genetically defective retinal degeneration, cellular therapies have been widely explored for restoring vision in both preclinical animal models and clinical trials. Stem cells of distinct tissue sources and their derived lineages have been tested for treating retinal degeneration; most of them were reported to be effective to some extent in restoring/improving deteriorated vision. Whether this visual improvement is due to a functional integration of grafted cells to substitute for lost retinal neurons in recipients or due to their neuroprotective and neurotrophic effects to retain recipient functional neurons, or both, is still under debate.METHODS:We compared the results of subretinal transplantation of various somatic cell types, such as stem cells and differentiated cells, into RhoP23H/+ mice, a retinal degeneration model for human retinitis pigmentosa (RP) by evaluating their optokinetic response (OKR) and retinal histology. We identified some paracrine factors in the media that cultured cells secreted by western blotting (WB) and functionally evaluated the vascular endothelial growth factor Vegfa for its potential neurotrophic and neuroprotective effects on the neuroretina of model animals by intravitreal injection of VEGF antibody.RESULTS:We found that live cells, regardless of whether they were stem cells or differentiated cell types, had a positive effect on improving degenerating retinas after subretinal transplantation; the efficacy depended on their survival duration in the host tissue. A few paracrine factors were identified in cell culture media; Vegfa was the most relevant neurotrophic and neuroprotective factor identified by our experiments to extend neuron survival duration in vivo.CONCLUSIONS:Cellular therapy-produced benefits for remediating retinal degeneration are mostly, if not completely, due to a paracrine effect of implanted cells on the remaining host retinal neurons.

Sustained neurotrophic factor cotreatment enhances donor and host retinal ganglion cell survival in mice

Modulation of microglia activation after human donor retinal ganglion cell transplantation

AAV-mediated Expression of CNTF Promotes Long-Term Survival and Regeneration of Adult Rat Retinal Ganglion Cells

Neuritin 1 Drives Therapeutic Preservation of Retinal Ganglion Cells in an Ex Vivo Human Glaucoma Model

Neuro-protection of Retinal Stem Cells Transplantation Combined with Copolymer-1 Immunization in a Rat Model of Glaucoma

Directly induced human retinal ganglion cells mimic fetal RGCs and are neuroprotective after transplantation in vivo

Neural Stem Cells Derived by Small Molecules Preserve Vision

Overexpression of Brain-Derived Neurotrophic Factor Protects Large Retinal Ganglion Cells After Optic Nerve Crush in Mice

Paracrine Effects of Intraocularly Implanted Cells on Degenerating Retinas in Mice.

Cooperative Effects of Bcl-2 and Aav-Mediated Expression of Cntf on Retinal Ganglion Cell Survival and Axonal Regeneration in Adult Transgenic Mice

Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo

Treatment of Adult Neural Progenitor Cells Prior to Transplantation Affects Graft Survival and Integration in A Neonatal and Adult Rat Model of Selective Retinal Ganglion Cell Depletion

Amelioration of Photoreceptor Degeneration by Intravitreal Transplantation of Retinal Progenitor Cells in Rats

Retinal Ganglion Cell Transplantation: Differentiation and Quantification Strategies

Human Retinal Progenitor Cell Transplantation Preserves Vision.

Interactive Effects of C3, Cyclic AMP and Ciliary Neurotrophic Factor on Adult Retinal Ganglion Cell Survival and Axonal Regeneration

Long-Term Rescue Of Rat Retinal Ganglion Cells And Visual Function By Aav-Mediated Bdnf Expression After Acute Elevation Of Intraocular Pressure

Novel engineered, membrane-localized variants of vascular endothelial growth factor (VEGF) protect retinal ganglion cells: a proof-of-concept study

In vivo Regeneration of Ganglion Cells for Vision Restoration in Mammalian Retinas

Different Optic Nerve Injury Sites Result in Different Responses of Retinal Ganglion Cells to Brain-Derived Neurotrophic Factor but Not Neurotrophin-4/5

Circular RNA-based therapy provides sustained and robust neuroprotection for retinal ganglion cells